Womens Imaging

Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.

A nonprofit healthcare-certification organization is challenging every user of medical ultrasound in the world to become proficient and certified in the modality by 2030.

COVID-19 set back screening mammography further than any other category of breast care, dropping schedule adherence during infection peaks to 36% of pre-pandemic rates.

mammography mammogram breast cancer

Researchers have combined three emerging technologies to detect and classify breast cancers found in follow-up imaging of women whose recent screening mammography was deemed normal.

AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.

Researchers have demonstrated a deep learning model that can correct course for breast radiologists who otherwise may have erroneously deemed tissue dense in screening exams.

Researcher considers greater role of AB-MRI for patients with personal history of breast cancer

Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.

The FDA has OK’d two subsidiaries of Los Angeles-based RadNet to sell medical AI software—one product for diagnosing breast cancer, the other for streamlining MRI prostate reporting workflows. 

Artificial intelligence can help make breast cancer screening mammography more accurate.

Combining ensemble AI models with reads from breast radiologists of mixed experience levels can help health systems consistently diagnose malignant architectural distortion on mammography.

AB-MRI is a cost-effective means of screening women with dense breast tissue for breast cancer—as long as the per-exam costs don’t top 82% of what would have been spent to perform full-protocol breast MRI.

Researchers recently completed an external validation for the Ovarian-Adnexal Reporting and Data System (O-RADS) for classifying lesions as malignant or benign, for which validation had been previously lacking. #ORADS

In addition to O-RADS external validation, experts also sought to determine if incorporating acoustic shadowing as a benign finding would improve diagnostic performance. 


Researchers revealed that less than 1% of more than 46,000 patients took advantage of online self-scheduling tools.

Using a handheld probe and smartphone, nurse midwives were able to estimate gestational age as accurately as certified sonographers.


Around the web

American Society of Nuclear Cardiology (ASNC) delegates to the American Medical Association (AMA) House of Delegates 2022 meeting Stephen Bloom, MD, and Nishant Shah, MD, explain a new AMA policy asking Congress to revise its clinician decision support mandate. 

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

American Medical Association President Gerald Harmon, MD, joined us for an exclusive chat about some of the hottest topics discussed at the 2022 AMA House of Delegates meeting.

Trimed Popup
Trimed Popup